Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines
Clinical trial NCT00001512 · COMPLETED
Trial details
- NCT number
- NCT00001512
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1996-09-09
- Primary completion
- 2010-03-05
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.